We love our customers — Save 10% on every order this month with code summer_10

Press + news

August 25, 2020

Codex DNA Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network

The Digital-to-Biological Converter will enable printing life-saving vaccines on a global scale using synthetic DNA to stop future pandemics

View press release

August 18, 2020

Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use

The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical new vaccines and biologics

View press release

July 16, 2020

Codex DNA Releases New Synthetic SARS-CoV-2 Genome for COVID-19 Vaccine and Therapeutic Research

New version represents dominant variant of the virus responsible for COVID-19 to enable relevant research and development of clinical treatments

View press release

April 9, 2020

Codex DNA announces 8 new products to support the scientific community’s battle against COVID-19

Pioneering synthetic DNA company releases a wide range of antigen panels, synthetic DNA parts, and vaccine scaffolds to expedite vaccine development, drug discovery, and diagnostics

View press release

April 6, 2020

SGI-DNA is now Codex DNA

Pioneering DNA synthesis company — inventor of the Gibson Assembly® method and the BioXp™ system — furthers its mission to empower researchers in moving “from reading DNA to writing and printing DNA”

View press release

February 18, 2020

SGI-DNA Equipping Researchers With Critical Tools to Combat Coronavirus Disease (COVID-2019)

Synthetic biology company taking major steps in worldwide effort to put a stop to the SARS-CoV-2 (formerly known as 2019-nCoV) outbreak, including co-funding purchases of BioXp™ 3200 System. SGI-DNA is enabling researchers to quickly print DNA required to discover vaccines and therapeutics.

View press release

January 31, 2020

SGI-DNA Launches Vmax™ X2, the Most Innovative Product in the Competent Cells Market Since the Discovery of E. coli

Pioneering synthetic biology company, SGI-DNA, releases a new protein expression system, accelerating research into vaccines and personalized medicines by delivering up to 4x more soluble protein than traditional E. coli methods in half the time.

View press release

December 23, 2019

SGI-DNA Appoints Brian Donnelly as Chief Commercial Officer

As we enter the most critical year in our company’s history—2020, we are pleased to announce that Brian Donnelly is joining our team as Chief Commercial Officer.

View press release

November 19, 2019

SGI-DNA Launches Gibson Assembly® RapidAMP™ Technology for its BioXp™ Gene Builder

The technology allows for mammalian transfection-ready DNA constructs to be synthesized, assembled into custom vectors, and amplified in a single day on the BioXp™ Gene Builder, eliminating the need to clone and copy DNA in E. coli.

View press release

October 1, 2019

Gibson Assembly® Advances Field of DNA Digital Data Storage

Gibson Assembly® strategy successfully employed to significantly increase the throughput of DNA data storage and retrieval.

View press release

September 9, 2019

SGI-DNA Secures $25 Million Series A Financing to Support Commercial Launch

Company using capital for the global commercial launch of the BioXp™ 3200 system — a fully automated gene synthesis and cloning platform powered by Gibson Assembly® Technology — and execution of its product roadmap for automated printing of biological materials and DNA data storage.

View press release

August 26, 2019

SGI-DNA Launches Multi-Tile Assembly Cloning (MTAC) Application for its BioXp™ 3200 Gene Builder

Multi-fragment cloning application leverages Gibson Assembly® technology to advance automated protein and antibody engineering capabilities and custom vector printing.

View press release

Questions? Suggestions? Need additional info?

The expertise of our scientists, engineers, and supporting teams is always available. Or call us: 858.228.4115